High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients

Postgraduate Medical Journal

Volumn 84, Issue 987, 2008, Pages 46-49

  Yuan, J ^a   Wang, H ^a   Wu, G ^a   Liu, H ^a   Zhang, Y ^a   Yang, L ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; POTASSIUM TITANYL PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; FOLLOW UP; HEMATOCRIT; HUMAN; LASER PROSTATECTOMY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PROSTATE HYPERTROPHY; RISK FACTOR; URINE VOLUME;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PHOSPHATES; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RISK FACTORS; TITANIUM; TREATMENT OUTCOME;

EID: 39049129845     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.062711     Document Type: Article

References (24)

1. Horninger W, Unterlechner H, Strasser H, et al. Transurethral prostatectomy: mortality and morbidity. Prostate 1996;28:195-200.
2. Uchida T, Ohori M, Soh S, et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999;53:98-105.
3. Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: immediate and postoperative complications, a cooperative study of 13 participating institutions evaluating 3885 patients. 1989. J Urol 2002;167:999-1003; discussion 1004.
4. van Melick HH, van Venrooij GE, Boon TA. Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. J Urol 2003;170:1851-5.
5. Reich O, Bachmann A, Siebeis M, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60.
6. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71; discussion 972.
7. Bachmann A, Ruszat R. The KTP-(greenlight-) laser: principles and experiences. Minim Invasive Ther Allied Technol 2007;16:5-10.
8. Fried NM. New laser treatment approaches for benign prostatic hyperplasia. Curr Urol Rep 2007;8:47-52.
9. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-6.
10. Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995;45:566-72.
11. Faul P, Farin G, Reich O, et al. The 'band electrode': first experiences with a novel TURP procedure to improve hemostasis. Eur Urol 1996;30:403-8.
12. Perlmutter AP, Schulsinger DA. The "Wedge" resection device for electrosurgical transurethral prostatectomy. J Endourol 1998;12:75-9.
13. Muschter R, Hofstetter A. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 1995;9:129-35.
14. Bihrle R, Foster RS, Sanghvi NT, et al. High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. J Urol 1994;151:1271-5.
15. Kabalin JN, Bite G, Doll S. Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 1996;155:181-5.
16. Reich O, Bachmann A, Schneede P, et al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171:2502- 4.
17. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83:227-37.
18. Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
19. Volkan T, Ihsan TA, Yilmaz O, et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 2005;48:608-13.
20. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004;14:21-5.
21. Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
22. Sulsør T, Reich O, Wyler S, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004;18:976-81.
23. Sandhu JS, Ng C, Vanderbrink BA, et al. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9.
24. Te AE, Malloy TR, Stein BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-8.